{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "P",
          "position": "30"
        },
        "variant_string_id": "SNCA A30P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Fibrillization of α-synuclein is central in Parkinson's pathogenesis.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines that α-synuclein fibrillization leads to Lewy body formation, which is a key feature."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Electron microscopy and immunochemical analysis were used.",
          "judgment": "Yes",
          "reasoning": "The assays directly assess protein aggregation, relevant to the disease mechanism."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "WT α-synuclein was used as a control.",
          "judgment": "Yes",
          "reasoning": "Standard methods were employed, validating the assay's applicability."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "A30P accelerates fibrillization and alters conformation.",
          "judgment": "Pathogenic effect shown",
          "reasoning": "The variant's role in promoting pathological aggregation supports a pathogenic classification."
        }
      ],
      "functional_evidence_strength": "PS3_moderate"
    }
  ]
}